Table 7 A use case study demonstrating NER-extracted antibodies against Omicron from relevant abstracts
From: Extract antibody and antigen names from biomedical literature
Antibodies | Number of supporting abstracts |
|---|---|
SOTROVIMAB | 14 |
CASIRIVIMAB | 8 |
IMDEVIMAB | 7 |
TIXAGEVIMAB | 4 |
CILGAVIMAB | 4 |
ETESEVIMAB | 3 |
AZD1061 | 3 |
BAMLANIVIMAB | 3 |
BEBTELOVIMAB | 3 |
EVUSHELD | 3 |
CT-P59 | 2 |
VIR-7831 | 2 |
S2K146 | 2 |
BNT162B2 | 2 |
REGDANVIMAB | 1 |
IMDEVIMA | 1 |
CASIVIRIMAB | 1 |
AZD8895 | 1 |
COV2-2196 | 1 |
COV2-2130 | 1 |
LY-COV016 | 1 |
LY-COV555 | 1 |
REGN10987 | 1 |
REGENERON | 1 |
REGN10933 | 1 |
S309 | 1 |
RONAPREVE | 1 |
ADINTREVIMAB | 1 |
S2H97 | 1 |
S2X259 | 1 |
ZF2001 | 1 |
S304 | 1 |
AKS-05 | 1 |
AKS-03 | 1 |
AKS-01 | 1 |
AKS-04 | 1 |
AKS-02 | 1 |
OCRELIZUMAB | 1 |
P5C3 | 1 |
P2G3 | 1 |
ZWD12 | 1 |
P2B-2F6 | 1 |
CB6 | 1 |
REGN | 1 |
B38 | 1 |
P2B2F6 | 1 |
CR3022 | 1 |
BRII-196 | 1 |
DXP-604 | 1 |
ADG20 | 1 |
SI-F019 | 1 |
IB20 | 1 |
IB14 | 1 |
58G6 | 1 |
IMM20253 | 1 |
IMM20190 | 1 |
IMM-BCP-01 | 1 |
IMM20184 | 1 |
35B5 | 1 |
ZCB11 | 1 |